Logo LenioBio GmbH

LenioBio GmbH

LenioBio is disrupting the way proteins are made with our proprietary cell-free protein production platform, ALiCE®. ALiCE® is fast, versatile, mobile, and rapidly scalable – an ideal PPP: a pandemic preparedness platform – and attributable to a broad range of other applications.

LenioBio holds an exclusive license from Dow/DuPont to develop and market the platform. Our ALiCE® expression kit and protein services generate revenues and open doors for strategic partnerships. LenioBio focuses now on scaling the technology to industrial scale. We received Seed funding and a Horizon 2020 grant in 2019.

ALiCE® Animation

PDF - LenioBio
Download (2 MB)

Roche Innovation Summit: Industry Pitching Session, June 23

The session of LenioBio at the Industry Pitching on June 23



LenioBio GmbH
Erkrather Straße 401
40231 Düsseldorf

Phone +49 (211) 890 940 30-0
E-mail: info@leniobio.com